{
    "nctId": "NCT03838419",
    "briefTitle": "Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer",
    "officialTitle": "Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 202,
    "primaryOutcomeMeasure": "Fatigue 12 weeks",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed invasive breast cancer\n* Total tumor size \\< 2.5 cm\n* cN0\n* estrogen receptor positive, HER2-receptor negative on immunohistochemistry\n* age \\>= 50 years\n* ECOG (Eastern Cooperative Oncology Group) Performance status \u2264 2\n* Ability of subject to understand character and individual consequences of the clinical trial\n* Written informed consent (must be available before enrolment in the trial)\n\nExclusion Criteria:\n\n* G3\n* Extensive microcalcifications\n* Invasive lobular carcinoma\n* Clinically involved lymph nodes\n* No invasive axillary lymph node staging planned\n* Patients with significant mental or physical comorbidities that preclude regular follow-up\n* Neoadjuvant chemotherapy or neoadjuvant endocrine therapy\n* previous radiotherapy of the breast\n* Known carcinoma \\< 5 years ago (excluding Carcinoma in situ of the cervix, basal cell carcinoma, squamous cell carcinoma of the skin) requiring immediate treatment interfering with study therapy\n* Pregnant or lactating women\n* Participation in another competing clinical study or observation period of competing trials",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}